MW_Nefrología de _1ed

270

Manual Washington de nefrología de trasplante

11. Lentine KL, Smith JM, Hart A, et al. OPTN/SRTR 2020 annual data report: kidney. Am J Transplant . 2022;22(suppl 2):21-136. 12. Israni AK, Salkowski N, Gustafson S, et al. New National allocation policy for deceased donor kidneys in the United States and possible Effect on patient outcomes. JASN (J Am Soc Nephrol) . 2014;25(8):1842-8. 13. Burns JM, Cornell LD, Perry DK, et al. Alloantibody levels and acute humoral rejection early after positive crossmatch kidney transplantation. Am J Transplant . 2008;8(12):2684-94. 14. Bentall A, Cornell LD, Gloor JM, et al. Five-year outcomes in living donor kidney trans plants with a positive crossmatch. Am J Transplant . 2013;13(1):76-85. 15. Orandi BJ, Chow EH, Hsu A, et al. Quantifying renal allograft loss following early anti body-mediated rejection. Am J Transplant . 2015;15(2):489-98. 16. Orandi BJ, Luo X, Massie AB, et al. Survival benefit with kidney transplants from HLA incompatible live donors. N Engl J Med . 2016;374(10):940-50. 17. Marfo K, Lu A, Ling M, Akalin E. Desensitization protocols and their outcome. CJASN . 2011;6(4):922-36. 18. Schinstock C, Tambur A, Stegall M. Current approaches to desensitization in solid organ transplantation. Front Immunol . 2021;12:686271. 19. Charlie W. Norwood Living Organ Donation Act . 2007. Accessed April 8, 2023. https://www.con gress.gov/bill/110th-congress/house-bill/710?q=%7B%22search%22%3A%5B%22char lie+norwood+living+organ+donation+act%22%5D%7D&s=3&r=4

Copyright © 2024 Wolters Kluwer, Inc. Unauthorized reproduction of the content is prohibited.